NASDAQ: PMAXPowell Max Ltd Stock
$0.39-0.02 (-4.88%)
Updated Apr 30, 2025
PMAX Price
$0.39
Fair Value Price
N/A
Market Cap
$5.73M
52 Week Low
$0.28
52 Week High
$4.70
P/E
-0.28x
P/B
0.27x
P/S
0.76x
PEG
N/A
Dividend Yield
N/A
Revenue
$36.46M
Earnings
-$18.07M
Gross Margin
39.4%
Operating Margin
-44.04%
Profit Margin
-49.6%
Debt to Equity
1.94
Operating Cash Flow
-$11M
Beta
1.2
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PMAX's potential to beat the market
- PMAX doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Diagnostic & Research
Industry Rating
B
PMAX
RankedUnranked of 44
RankedUnranked of 44
Be the first to know about important PMAX news, forecast changes, insider trades & much more!
PMAX News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PMAX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PMAX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PMAX is good value based on its book value relative to its share price (0.27x), compared to the US Diagnostics & Research industry average (3.39x)
P/B vs Industry Valuation
PMAX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PMAX due diligence checks available for Premium users.
Valuation
PMAX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.28x
Industry
39.05x
Market
29.18x
PMAX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.27x
Industry
3.39x
PMAX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PMAX's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
PMAX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PMAX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$62.6M
Liabilities
$41.3M
Debt to equity
1.94
PMAX's short-term assets ($58.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PMAX's short-term assets ($58.32M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PMAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
PMAX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PMAX vs Diagnostic & Research Stocks
Powell Max Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.